Lymphocytic choriomeningitis virus

4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Australian Research Council and 1 more

Outcomes

Cellular senescence

downin mice1

1 study

Lymphocytic choriomeningitis virus decreases cellular senescence in mice.
“coincident with an attenuation of the senescent TVM cell phenotype”
Animals
LCMV-mediated loss of virtual memory CD8 T cells yields a functionally enhanced T cell subset
iScience28 Oct 2025

Lymphocytic choriomeningitis virus

Outcomes

Related